1. Home
  2. JBLU vs ODTX Comparison

JBLU vs ODTX Comparison

Compare JBLU & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JetBlue Airways Corporation

JBLU

JetBlue Airways Corporation

N/A

Current Price

$3.31

Market Cap

1.1B

ML Signal

N/A

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$16.90

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JBLU
ODTX
Founded
1998
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2002
2025

Fundamental Metrics

Financial Performance
Metric
JBLU
ODTX
Price
$3.31
$16.90
Analyst Decision
Hold
Strong Buy
Analyst Count
17
8
Target Price
$4.24
★ $34.67
AVG Volume (30 Days)
★ 29.4M
291.0K
Earning Date
10-26-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 27.83
N/A
EPS
★ N/A
N/A
Revenue
★ $9,062,000,000.00
N/A
Revenue This Year
$16.26
N/A
Revenue Next Year
$9.23
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.16
$15.10
52 Week High
$6.62
$29.05

Technical Indicators

Market Signals
Indicator
JBLU
ODTX
Relative Strength Index (RSI) 43.37 36.09
Support Level $2.16 $15.73
Resistance Level $6.28 $19.60
Average True Range (ATR) 0.23 1.69
MACD 0.01 -0.19
Stochastic Oscillator 15.63 6.10

Price Performance

Historical Comparison
JBLU
ODTX

About JBLU JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: